Here is the detailed overview of Buprenorphine Tablet (Sublingual) 0.4 mg with icons:
๐ Buprenorphine Sublingual Tablet 0.4 mg
๐งช Nature / Drug Class
๐น Partial opioid agonist
๐น Acts on ฮผ-opioid receptors
๐น Sublingual route (placed under the tongue) for better absorption
๐น Controlled / regulated medicine under NDPS (India)
๐ฉบ Purpose / Indications
โ Used for:
- ๐ Opioid dependence / maintenance therapy
- ๐ข Moderate to severe pain management (less common at this low dose)
- Often used in de-addiction programs
โ๏ธ Advantages
โ๏ธ Long-acting โ allows once or twice daily dosing
โ๏ธ Lower risk of respiratory depression compared to full agonists
โ๏ธ Reduced withdrawal symptoms
โ๏ธ Ceiling effect on respiratory depression โ safety margin
โ๏ธ Suitable for home-based opioid treatment (with monitoring)
๐ฆ Common Packaging
๐ฆ Available as:
- 0.4 mg sublingual tablets
- Often packed in blister strips of 10 tablets
๐ Dispensed under strict supervision or prescription (often in de-addiction centers)
โ ๏ธ Patient Advice / Precautions
๐
Do not chew or swallow; place under tongue until fully dissolved
๐ Avoid food/drink for 15 minutes after use
๐ซ Do not share โ serious misuse potential
๐งพ Regular follow-up needed for dose adjustment
๐ง Maintain hydration and oral hygiene
โ ๏ธ Do not stop suddenly โ risk of withdrawal symptoms
๐ซ Contraindications / Cautions
โ Severe respiratory depression
โ Liver failure
โ Concurrent use of alcohol or sedatives increases risk of sedation
โ ๏ธ Use with caution in:
- Pregnancy (specialized protocols required)
- Head injury or CNS depression
๐ง Storage
๐ก๏ธ Store at room temperature (15โ30ยฐC)
๐ Keep in secure location โ risk of abuse
๐ง Keep out of reach of children